These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2961063)

  • 21. Plasminogen activation at the cell surface-matrix interface.
    Vaheri A; Stephens RW; Salonen EM; Pöllänen J; Tapiovaara H
    Cell Differ Dev; 1990 Dec; 32(3):255-62. PubMed ID: 2151565
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urokinase-dependent cell surface proteolysis and cancer.
    Blasi F; Verde P
    Semin Cancer Biol; 1990 Apr; 1(2):117-26. PubMed ID: 2151734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of glycoprotein and collagenous components of the basement membrane: studies with urokinase-type plasminogen activator, alpha-thrombin, and plasmin.
    Goldfarb RH; Murano G; Brundage R; Siegal GP; Terranova V; Garbisa S; Liotta LA
    Semin Thromb Hemost; 1986 Oct; 12(4):335-6. PubMed ID: 2947330
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in clinical fibrinolysis.
    Hessel LW; Kluft C
    Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells.
    Lu H; Mirshahi M; Krief P; Soria C; Soria J; Mishal Z; Bertrand O; Perrot JY; Li H; Picot C
    Biochem Biophys Res Commun; 1988 Aug; 155(1):418-22. PubMed ID: 2843185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular receptors in the regulation of plasmin generation.
    Hajjar KA
    Thromb Haemost; 1995 Jul; 74(1):294-301. PubMed ID: 8578475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of human Glu-plasminogen to Glu-plasmin by urokinase in presence of plasmin inhibitors. Streptomyces leupeptin and human plasma alpha1-antitrypsin and antithrombin III (plus heparin).
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    J Biol Chem; 1977 Jun; 252(11):3945-51. PubMed ID: 140876
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide.
    Sodetz JM; Brockway WJ; Mann KG; Castellino FJ
    Biochem Biophys Res Commun; 1974 Sep; 60(2):729-36. PubMed ID: 4278813
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen.
    DePoli P; Bacon-Baguley T; Kendra-Franczak S; Cederholm MT; Walz DA
    Blood; 1989 Mar; 73(4):976-82. PubMed ID: 2522013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of thrombospondin to immobilized ligands: specific interaction with fibrinogen, plasminogen, histidine-rich glycoprotein, and fibronectin.
    Walz DA; Bacon-Baguley T; Kendra-Franczak S; DePoli P
    Semin Thromb Hemost; 1987 Jul; 13(3):317-25. PubMed ID: 3686023
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasminogen activators and angiogenesis.
    Mignatti P; Rifkin DB
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():33-50. PubMed ID: 8814993
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasminogen activation on tumor cell surface and its involvement in human leukemia.
    Tapiovaara H; Alitalo R; Vaheri A
    Adv Cancer Res; 1996; 69():101-33. PubMed ID: 8791680
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.
    Whur P; Silcox JJ; Boston JA; Williams DC
    Br J Cancer; 1979 Jun; 39(6):718-30. PubMed ID: 156038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for high-molecular weight active peptides originating from porcine plasmin autolysis.
    Grimard M
    Biochimie; 1976; 58(11-12):1409-12. PubMed ID: 138450
    [No Abstract]   [Full Text] [Related]  

  • 38. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.
    Rijken DC; Hoylaerts M; Collen D
    J Biol Chem; 1982 Mar; 257(6):2920-5. PubMed ID: 7199525
    [No Abstract]   [Full Text] [Related]  

  • 39. The plasminogen-plasmin system in malignancy.
    Kwaan HC
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):291-311. PubMed ID: 1423820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of fibrinolysis by thrombospondin.
    Mosher DF; Misenheimer TM; Stenflo J; Hogg PJ
    Ann N Y Acad Sci; 1992 Dec; 667():64-9. PubMed ID: 1309073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.